Selective Estrogen receptor degraders (SERDs) for the treatment of breast cancer: An overview-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selective Estrogen receptor degraders (SERDs) for the treatment of breast cancer: An overview

Published:2023-08 Issue: Volume:256 Page:115422
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Bhatia Neha,Hazra Shreejita,Thareja Suresh^ORCID

Funder

Department of Science and Technology, Ministry of Science and Technology, India

All India Council for Technical Education

University of Central Punjab

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference128 articles.

1. Various types and management of breast cancer: an overview;Sharma;"J. Adv. Pharm. Technol. Research"" (JAPTR)",2010

2. Breast reconstruction after surgery for breast cancer;Cordeiro;N. Engl. J. Med.,2008

3. Cadherins and catenins in breast cancer;Cowin;Curr. Opin. Cell Biol.,2005

4. The lingering mysteries of metastatic recurrence in breast cancer;Riggio;Br. J. Cancer,2021

5. Oral selective estrogen receptor degraders (SERDs) as a novel breast cancer therapy: present and future from a clinical perspective;Hernando;Int. J. Mol. Sci.,2021

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aromatase inhibitors for the treatment of breast cancer: An overview (2019–2023);Bioorganic Chemistry;2024-10

2. Discovery and prospects of new heterocyclic Isatin-hydrazide derivative with a novel role as estrogen receptor α degrader in breast cancer cells;Frontiers in Chemistry;2024-07-03

3. Oral SERDs alone or in combination with CDK 4/6 inhibitors in breast cancer: Current perspectives and clinical trials;The Breast;2024-06

4. The discovery of potent USP2/USP8 dual-target inhibitors for the treatment of breast cancer via structure guided optimization of ML364;European Journal of Medicinal Chemistry;2024-03

5. Male Breast Cancer: Current Scenario and Future Perspectives;Technology in Cancer Research & Treatment;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3